Evidence map›Paper›PMID 20121730›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2010

Recipient dendritic cells, but not B cells, are required antigen-presenting cells for peripheral alloreactive CD8+ T-cell tolerance.

J L Mollov, C L Lucas, F Haspot, J Kurtz C Gaspar, A Guzman, M Sykes

Abstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Induction of tolerance through mixed chimerism.Cold Spring Harbor perspectives in medicine · 2014
    Review
  7. Review
  8. Article
  9. Transplantation tolerance through mixed chimerism.Nature reviews. Nephrology · 2010
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

J L Mollov *Transplantation Biology Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
C L Lucas *Transplantation Biology Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
F Haspot *Transplantation Biology Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
J Kurtz C GasparTransplantation Biology Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
A GuzmanTransplantation Biology Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
M SykesTransplantation Biology Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA.

Funding

TRAINING IN CELL STRUCTURE AND FUNCTION IN NEPHROLOGYT32DK007540 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS, SOBERMAN, ROY · 1986 to 2021
$7.2M
MIXED CHIMERISM AS AN APPROACH TO TRANSPLANT TOLERANCER01HL049915 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI SYKES, MEGAN · 1993 to 2010
$3.9M
Alcohol abuse exacerbates bronchiolitis obliteransF32AA016262 · NIAAA · EMORY UNIVERSITY · PI MITCHELL, PATRICK O · 2006 to 2007
$89k
NHLBI NIH HHS R01 HL049915NHLBI NIH HHS R01 HL49915NIAAA NIH HHS F32 AA016262NIDDK NIH HHS T32 DK007540NIDDK NIH HHS T32DK007540-21
6 · The paper itself

Abstract

Induction of mixed allogeneic chimerism is a promising approach for achieving donor-specific tolerance, thereby obviating the need for life-long immunosuppression for solid organ allograft acceptance. In mice receiving a low dose (3Gy) of total body irradiation, allogeneic bone marrow transplantation combined with anti-CD154 tolerizes peripheral CD4 and CD8 T cells, allowing achievement of mixed chimerism with specific tolerance to donor. With this approach, peripheral CD8 T-cell tolerance requires recipient MHC class II, CD4 T cells, B cells and DCs. Recipient-type B cells from chimeras that were tolerant to donor still promoted CD8 T-cell tolerance, but their role could not be replaced by donor-type B cells. Using recipients whose B cells or DCs specifically lack MHC class I and/or class II or lack CD80 and CD86, we demonstrate that dendritic cells (DCs) must express CD80/86 and either MHC class I or class II to promote CD8 tolerance. In contrast, B cells, though required, did not need to express MHC class I or class II or CD80/86 to promote CD8 tolerance. Moreover, recipient IDO and IL-10 were not required. Thus, antigen presentation by recipient DCs and not by B cells is critical for peripheral alloreactive CD8 T cell tolerance.

Indexed as

AnimalsAntigen-Presenting CellsB7-1 AntigenB7-2 AntigenB-LymphocytesCD40 LigandCD8-Positive T-LymphocytesDendritic CellsFemaleHistocompatibility AntigensImmune ToleranceInterleukin-10MiceMice, Inbred C57BLTransplantation ConditioningB7-1 AntigenB7-2 AntigenCD40 LigandHistocompatibility AntigensInterleukin-10

Identifiers

PMID20121730
PMCPMC4215806

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.